Latest Headlines

  1. Sartorius Stedim Biotech And Lonza Modify Relationship For Supply Of Cell Culture Media

    Sartorius Stedim Biotech (SSB), a leading international supplier of the biopharmaceutical industry, and Lonza announced recently that they have modified their current agreement for supply of cell culture media by mutual accord.

  2. NIIMBL Publishes Technology Roadmaps For Biopharmaceutical Manufacturing Industry

    The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce the publication of three technology roadmaps designed to benefit the biopharmaceutical community.

  3. MilliporeSigma Launches BioContinuum™ Platform For Next-Generation Process Improvements

    MilliporeSigma recently launched its new BioContinuum Platform to advance biotherapeutic drug manufacturing through improved efficiency, simplified plant operations and greater quality and consistency.

  4. Flexible Containment Equipment Provider To Build New Manufacturing Facility In Ireland

    ILC Dover has announced its expansion with a new facility in Blarney, Co Cork which is set to create 70 jobs over two years.

  5. Flow Sciences’ Glove Boxes Contain To Sub-Nano Levels

    Flow Sciences, a leading provider of containment systems for laboratory, pilot plant, and manufacturing facilities has recently proven through third-party acceptance testing that their gloveboxes can facilitate an interior concentration of less than 1 ng/m3.

  6. Cybersecurity Threats To Pharma: What You Should Know

    Who would want to hack a programmable logic controller? If you have watched any news as of late, you will notice a routine story line about the occurrences of cybersecurity attacks. It seems that the hackers are working over time trying to cause all manner of trouble.

  7. Meet Bosch At ISPE Annual Meeting, AAPS And SupplySide West Conferences November 2018

    No matter which show or conference you plan to attend the week of November 4th, Bosch will be there to meet you. Our team is excited to show you Bosch’s

  8. Shionogi Announces FDA Approval Of XOFLUZA (Baloxavir Marboxil) For The Treatment Of Acute, Uncomplicated Influenza

    Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President and CEO: Isao Teshirogi, Ph.D.; hereafter "Shionogi") announced recently that, after completing a Priority Review, the United States Food and Drug Administration (FDA) has approved XOFLUZA (baloxavir marboxil) for the treatment of acute, uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours.

  9. Lonza Opens Cell And-Gene-Therapy Center Of Excellence In Texas

    Lonza reported it opened “the world’s largest dedicated cell and-gene-therapy Center of Excellence,” in Pearland, Texas. The COE is expected to reach 200 full-time staff by end of 2018 in greater Houston and continue to recruit high-value positions as market demand increases.

  10. Meissner Is Pleased To Announce Its Participation In The BioProduction Congress 2018, Dublin, Ireland!

    BioProduction Congress, co-located with the Bioanalytical and Formulation Summit, will be held October 9th-10th, 2018, at the Convention Centre Dublin, Ireland.